Mersana Therapeutics buy michaelkr
Start price
11.06.23
/
50%
€8.07
Target price
11.06.24
-
Performance (%)
-65.32%
End price
23.06.23
€2.80
Summary
This prediction ended on 23.06.23 with a price of €2.80. The BUY prediction by michaelkr for Mersana Therapeutics performed very badly with a performance of -65.32%. michaelkr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Mersana Therapeutics | - | - | - |
iShares Core DAX® | 1.560% | 4.721% | 18.671% |
iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% |
iShares Nikkei 225® | 1.730% | 6.073% | 16.253% |
iShares S&P 500 | 1.482% | 1.218% | 23.290% |
According to michaelkr what are the pros and cons of Mersana Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by michaelkr for this prediction
In the thread Mersana Therapeutics diskutieren
Buy Mersana Therapeutics
In the thread Trading Mersana Therapeutics
Buy beendet
Stopped prediction by michaelkr for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.12
14.08.24
14.08.24
-
14.08.25
14.08.25
6.38%
18.08.24
18.08.24
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.00
22.06.24
22.06.24
-
22.06.25
22.06.25
-17.76%
02.07.24
02.07.24
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.86
10.12.23
10.12.23
-
10.12.24
10.12.24
7.53%
23.12.23
23.12.23
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.00
27.07.23
27.07.23
-
27.07.24
27.07.24
12.35%
05.08.23
05.08.23
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€3.50
10.07.23
10.07.23
-
10.07.24
10.07.24
-1.86%
22.07.23
22.07.23
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€6.15
28.11.21
28.11.21
-
28.11.22
28.11.22
-15.45%
12.12.21
12.12.21
Could be very worthwhile Investment >20% year